MARKET

GSK

GSK

GSK PLC
NYSE
33.60
+0.17
+0.51%
After Hours: 33.65 +0.05 +0.15% 19:02 12/20 EST
OPEN
33.14
PREV CLOSE
33.43
HIGH
33.87
LOW
33.04
VOLUME
6.81M
TURNOVER
--
52 WEEK HIGH
44.85
52 WEEK LOW
32.83
MARKET CAP
69.64B
P/E (TTM)
20.62
1D
5D
1M
3M
1Y
5Y
1D
GlaxoSmithKline (GSK) Gets a Hold from Barclays
TipRanks · 2d ago
GSK reports mixed results from Phase 3 ovarian cancer study
Seeking Alpha · 2d ago
GSK announces FIRST advanced ovarian cancer trial met primary endpoint
TipRanks · 3d ago
GSK Hits Key Milestone in Ovarian Cancer Trial
TipRanks · 3d ago
GlaxoSmithKline (GSK) Gets a Hold from Goldman Sachs
TipRanks · 3d ago
California Gov. Newsom declares State of Emergency over bird flu
Seeking Alpha · 4d ago
Cautious Outlook on GlaxoSmithKline: Sell Rating Due to Pipeline and Financial Challenges
TipRanks · 5d ago
Deutsche Bank Keeps Their Hold Rating on GlaxoSmithKline (GSK)
TipRanks · 6d ago
More
About GSK
GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes over 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases. It is advancing oligonucleotide therapeutics in chronic hepatitis B and steatotic liver disease as well as other therapeutic areas beyond liver disease.

Webull offers GSK plc (ADR) stock information, including NYSE: GSK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GSK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GSK stock methods without spending real money on the virtual paper trading platform.